Comparative Study of the effect of Flobel Syrup with Magnesium Hydroxide Syrup in the treatment of constipation in pregnant women: A Randomized Clinical Trial
Comparison of the effect of Flobel syrup with magnesium hydroxide syrup in the treatment of constipation in pregnant women referred to Mobini Sabzevar Hospital.
Design
کارآزمایی بالینی دارای گروه کنترل و مداخله موازی، یک سویه کور، تصادفی شده، فاز 3، بر روی 70 بیمار،تعیین بلوک های تصادفی با کمک نرم افزارRandom Allocation انجام می شود.
Settings and conduct
This study will be conducted in 1403 at Mobini Hospital in Sabzevar city, Razavi Khorasan, Iran.
In the control group, magnesium hydroxide syrup and in the intervention group, Flobel syrup.
First, eligible pregnant mothers are selected by gynecologists and entered into the study.
In the intervention group, the patient consumes Flobel syrup twice a day in the amount of one tablespoon equivalent to 10 cc for two weeks. If constipation does not improve, patients can increase the dose of medicine up to 30 cc daily. In the control group, the patient consumes 30-60 cc of magnesium hydroxide daily.
Participants/Inclusion and exclusion criteria
Entry requirements:
Age 15-45 years
Gestational age 5 to 35 weeks
Diagnosing constipation based on ROME IV criteria (having bowel movements less than 3 times a week, pain during defecation and hard stools).
Non-entry conditions:
high risk pregnancy
History of inflammatory bowel diseases
Having a history of bowel surgery
Smoking and drug abuse
Use of other laxatives
Intervention groups
The control group will use magnesium hydroxide syrup and the intervention group will use Flobel syrup. First, pregnant mothers referring to the women's clinic of Mobini Hospital of Sabzevar University of Medical Sciences with complaints of constipation (based on ROME IV criteria) who are eligible to enter the project are selected by gynecologists and entered into the study.
Main outcome variables
Frequency of bowel movements per week was the primary outcome.
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20240303061150N1
Registration date:2024-04-08, 1403/01/20
Registration timing:prospective
Last update:2024-04-08, 1403/01/20
Update count:0
Registration date
2024-04-08, 1403/01/20
Registrant information
Name
ali rezaei
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 58 3723 5163
Email address
rezaeia97@medsab.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-05-21, 1403/03/01
Expected recruitment end date
2024-10-22, 1403/08/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparative Study of the effect of Flobel Syrup with Magnesium Hydroxide Syrup in the treatment of constipation in pregnant women: A Randomized Clinical Trial
Public title
Comparative Study of the effect of Flobel Syrup on constipation in pregnant women
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Gestational age 5 to 35 weeks
Diagnosing constipation based on ROME IV criteria (having bowel movements less than 3 times a week, pain during defecation and hard stools).
Exclusion criteria:
high risk pregnancy
History of inflammatory bowel diseases
Having a history of bowel surgery
Smoking and drug abuse
Use of other laxatives
Age
From 15 years old to 45 years old
Gender
Male
Phase
3
Groups that have been masked
Participant
Sample size
Target sample size:
70
Randomization (investigator's opinion)
Randomized
Randomization description
Block randomization method (permuted block randomization) patients are assigned to two intervention and control groups. Considering that we are supposed to have 35 samples in each group (70 people in total), we use 7 blocks of 10 members for this purpose. Inside each block, 5 people are assigned to the intervention group and 5 people to the control group. Random blocks are determined with the help of Random Allocation software. In order to hide the random allocation, we will use opaque sealed envelopes with a random sequence. In this method, after creating a random sequence with the help of the software, a number of envelopes are prepared based on the sample size, each of the created random sequences is recorded on cards and placed inside the envelopes (every 10 envelopes corresponding to is a block). Then, based on the order of entry of eligible participants into the study, one of the envelopes related to the desired block is opened and the group assigned to the patient is determined. For the purpose of blinding, random allocation will be made with irregular codes and a combination of numbers and letters, and these codes will be recorded on the envelopes instead of numbers, so that the researcher cannot, when preparing the envelopes, due to the irregular codes on the envelopes. Guess the designated group inside the envelope. It will not be known to the patients what medicine they will receive and thus blinding will be done
Blinding (investigator's opinion)
Single blinded
Blinding description
Considering that we are supposed to have 35 samples in each group (70 people in total), we use 7 blocks of 10 members for this purpose. Inside each block, 5 people are assigned to the intervention group and 5 people to the control group. In order to hide the random allocation, we will use opaque sealed envelopes with a random sequence. In this method, after creating a random sequence with the help of the software, a number of envelopes are prepared based on the sample size, each of the created random sequences is recorded on cards and placed inside the envelopes (every 10 envelopes corresponding to is a block). Then, based on the order in which the eligible participants entered the study, one of the envelopes related to the desired block is opened and the group assigned to the patient is determined. For the purpose of blinding, random allocation will be made with irregular codes and a combination of numbers and letters, and these codes will be recorded on the envelopes instead of numbers, so that the researcher cannot, when preparing the envelopes, due to the irregular codes on the envelopes. Guess the designated group inside the envelope. It will not be known to the patients what medicine they will receive and thus blinding will be done.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of Sabzevar University of Medical Sciences
Street address
research and technology vice-chancellor,university of medical sciences ,nuclear martyrs boulevard, above the memorial of unknown martyrs,nuclear martyrs boulevard, sabzevar,iran
City
sabzevar
Province
Razavi Khorasan
Postal code
9617913112
Approval date
2024-03-02, 1402/12/12
Ethics committee reference number
IR.MEDSAB.REC.1402.128
Health conditions studied
1
Description of health condition studied
constipation
ICD-10 code
K59.0
ICD-10 code description
Constipation
Primary outcomes
1
Description
Frequency of bowel movements per week
Timepoint
week
Method of measurement
number
Secondary outcomes
1
Description
Pain during bowel movements
Timepoint
week
Method of measurement
The intensity of pain during each bowel movement
2
Description
Stool stiffness
Timepoint
week
Method of measurement
The degree of firmness of stool in each bowel movement
Intervention groups
1
Description
Intervention group: Flobel syrup will be used in the intervention group. At first, pregnant mothers with complaints of constipation (based on ROME IV criteria) who are eligible to enter the project are selected by gynecologists and entered into the study. In the intervention group, the patient will drink Floss syrup twice a day for two weeks. Sanabel consumes the drug) in the amount of one tablespoon equal to 10 cc. If constipation does not improve, patients can increase the dose of medicine up to 30 cc daily.
Category
Treatment - Drugs
2
Description
Control group: In the control group, the patient consumes 30-60 cc of magnesium hydroxide daily.